Hyperbaric oxygen treatment for toxic epidermal necrolysis: A case report

Diving Hyperb Med. 2021 Jun 30;51(2):216-219. doi: 10.28920/dhm51.2.216-219.

Abstract

Toxic epidermal necrolysis (TEN) is a potentially life-threatening muco-cutaneous disease, largely caused by an idiosyncratic reaction to medication or infectious disease, and is characterised by acute necrosis of the epidermis. No definitive consensus regarding the treatment of TEN has been agreed. A 60-year-old woman, diagnosed with multiple myeloma three months prior, was admitted with signs of TEN to the intensive care burns unit. She had been given ciprofloxacin to treat a urinary tract infection. She complained of malaise and pain, with maculopapular and bullous eruptions over her whole body on the third day of ciprofloxacin administration. Her supportive cares included intravenous immunoglobulins, pain control with analgesics, wound care, nutrition, and fluid support. Hyperbaric oxygen treatment (HBOT) was added on the second day of admission. The patient underwent 5 sessions of HBOT at 243.1 kPa (2.4 atmospheres absolute). Desquamation was noted to stop after the first session of HBOT and re-epithelisation commenced rapidly. The patient was discharged from the burn unit after 14 days of hospital admission. Improvement in this case was temporally related to the initiation of HBOT.

Keywords: Case reports; Drugs; Hyperbaric medicine; Outcome; Side effects; Skin; Toxicity.

Publication types

  • Case Reports

MeSH terms

  • Critical Care
  • Female
  • Humans
  • Hyperbaric Oxygenation*
  • Middle Aged
  • Oxygen
  • Stevens-Johnson Syndrome* / therapy

Substances

  • Oxygen